Nevirapine programme finally gets the go-ahead
Provinces are finally expected to get the go-head today (Tuesday, June 5th) to give HIV positive women the drug, nevirapine, to prevent them from passing the virus on to their babies.
Health Minister Dr Manto Tshabalala Msimang is to make this announcement later today in her Budget speech to Parliament, according to sources close to the minister.
The minister unilaterally delayed the implementation of the 18 provincial mother-to-child pilot programmes due to start on 1 April when she decided that they needed Cabinet approval.
However, since then she has failed to present the matter to Cabinet – largely because she has been attending a series of meetings outside the country.
The Western Cape and Gauteng have already started their nevirapine programmes, while KwaZulu-Natal, the Free State and the Northern Cape have been ready to do so since early April.
However, the late registration of nevirapine – which was finally approved by the Medicines Control Council on 18 April – and the minister’s decision to refer the matter to Cabinet has caused confusion in the provinces.
A number of provincial health officials involved in the MTCT programmes said they had been told not to speak to the press, but said they were extremely frustrated by the delay as it was at the cost of babies’ lives.
An estimated 200 HIV positive babies are born in South Africa every day, most of whom die before the age of five. The country’s longest surviving child infected via his mother, Nkosi Johnson, died on Friday.
Had Johnson’s mother been given a single tablet of nevirapine in labour and he been given a tablet shortly after birth, his chances of getting HIV could have been reduced by about 40%.
Nevirapine’s manufacturer, Boehringer Ingelheim has offered the drug free to all SADC countries for a period of five years.
Treatment Action Campaign spokesperson Nathan Geffen said it would be “good news” if all pilots could go ahead. However, he pointed out that the18 pilots would only reach about 10% of HIV positive pregnant women, and called on government to roll out the programme as soon as possible.
Author
-
Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews
View all posts
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Nevirapine programme finally gets the go-ahead
by Health-e News, Health-e News
June 5, 2001